Back to search

Germany· DE-A57-4eb28ce527f3d975

Cefalexin Reiwa Healthcare

A cefalexin product containing cefalexin monohydrate, registered in Germany by Reiwa Healthcare S.L. The same ATC class is registered in 14 of our 19 countries.

ATC J01DB01

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedCefalexin Reiwa HealthcareATCJ01DB01REGISTER NO.DE-A57-4eb28ce527f3d9…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Cefalexin is registered in 14 of 19 countries.

Countries holding a registration under ATC J01DB01 (cefalexin), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 7 of them publish a price we can compare per daily dose

Cefalexin · ATC J01DB01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefalexin costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $0.72 in United States to $1.28 in Spain — a ×1.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Cefalexin · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • ES Spain$1.28
  • US United States$0.72 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Cefalexin Monohydrate
Manufacturer
Reiwa Healthcare S.L
Country
Germany (DE)
ATC code
J01DB01
ATC class
Cefalexin
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

223 interactions on record for cefalexin.

Graded by severity as the source publishes them — 13 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefalexin · interactions on record

223 records

  • 13 moderate
  • 210 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • BalsalazideA07EC04moderate
  • MetforminA10BA02moderate
  • DicoumarolB01AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefalexin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefalexin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Cephalobene, Keflex
  • Belgium · Keforal
  • Bulgaria · Оспексин
  • Cyprus · Felexin, Keflex
  • Denmark · Keflex
  • Spain · Cefalexina Normon, Cefalexina Reiwa Healthcare
  • Finland · Kefalex, Kefexin
  • France · Keforal, Kéforal
  • United Kingdom (Northern Ireland) · Cefalexin, Cefalexin Ascend Laboratories (Uk)
  • Croatia · Cefaleksin Belupo, Cefalexin Alkaloid
  • Hungary · Cefalexin Reiwa Healthcare, Pyassan 250 Mg Kemény Kapszula
  • Ireland · Keflex
  • Italy · Ceporex, Keforal
  • Luxembourg · Keforal
  • Malta · Keflex
  • Netherlands · Keforal
  • Norway · Keflex
  • Poland · Cefaleksyna Tzf
  • Romania · Cefalexină Arena, Cefalexina Atb
  • Slovakia · Ospexin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7dbdcfee-5a30-427f-959c-3f3ccf3c5cf5
GET /v1/drugs/7dbdcfee-5a30-427f-959c-3f3ccf3c5cf5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Cefalexin Monohydrate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about cefalexin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.